PASG Q1 2022 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$29M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$43M

Net Income

-$43M

EPS (Diluted)

$-15.80

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$47M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$333M

Total Liabilities

$52M

Stockholders' Equity

$281M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$43M	-$39M	-10.0%
Net Income	-$43M	-$39M	-10.1%